Registry of Celution Device for Processing ADRCs and Healing in Muscle and Ligament Sports Injuries
NCT ID: NCT02770755
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2014-09-30
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Scleroderma Treatment With Celution Processed ADRCs Registry
NCT02328625
An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds
NCT03723603
ENgineered Tissue Repair of BronchopleUral FiSTula
NCT04435249
Human Tissue Repository for Wound Care
NCT01432054
Adipose-derived Stem Cells to Treat Chronic Wounds.
NCT05797688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with sports related muscle tear (≥5%) with or without ligament injury as confirmed by ultrasound or MRI with onset of injury in preceding year
* Pain in the affected area at rest and/or movement
* Weakness or inability to use affected muscle
Exclusion Criteria
* Known spine or disc disease or symptomatic impingement of nerve root
* Known neuromuscular disease (e.g., amyotrophic lateral sclerosis, muscular dystrophy)
* History of documented nerve damage in the affected limb
* Tears involving open wounds
* Tears requiring surgical repair
* Pregnant or lactating status. Pregnancy as determined by a positive pregnancy test at screening or baseline
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cytori Therapeutics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven Kesten, M.D.
Role: STUDY_CHAIR
Cytori Therapeutics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Football Association
Wembley, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACHILLES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.